Lip GYH, Tse HF, Lane DA, Apostolakis S. Atrial fibrillation. The Lancet 2012; 379: 648-661. Clinical Evidence 2011 [citado em 03 Jjul 2012]; 02:210.

University of Birmingham. National Institute for Health Research. National Horizon Scanning Centre (NHSC). Vernakalant (IV) (Brinavess) for the treatment of recent onset atrial fibrillation. May 2010. [citado em 03 Jul 2012]; Disponível em: http://www.nhsc-healthhorizons.org.uk/topics/vernakalant-kynapid-for-atrial-fibrilliation-recen/.

Klasco RK (Ed): Martindale: The Complete Drug Reference. Thomson MICROMEDEX, Greenwood Village, Colorado, USA. [citado em 02 Jul 2012]; Disponível em:

http://www.thomsonhc.com/.

Camm AJ, Capucci A, Hohnloser S, et al. A Randomized Active-Controlled Study Comparing the Efficacy and Safety of Vernakalant to Amiodarone in Recent-Onset Atrial Fibrillation. Journal of the American College of Cardiology 2011; 57(3): 314-321. [citado em 02 Jul 2012] Disponível em: http://content.onlinejacc.org/article.aspx?articleid=1144058.